Jason Lester
Dr Jason Lester is a senior consultant clinical oncologist specialising in lung cancer and urological cancers. Following medical training
in London and oncology training in Cardiff, UK, Dr Lester has been a consultant oncologist for 15 years and is currently deputy clinical
director of Velindre Cancer Centre, and chairman of the Rutherford Cancer Centre Local Medical Advisory Committee for Wales. He is
also the clinical lead for the All Wales Prostate Cancer Brachytherapy Service. Dr Lester has been involved in numerous clinical trials in
both lung and urological cancer, and has published extensively in these fields. He is the lead investigator for the I-START trial, which is
investigating dose-escalated radiotherapy, and the SKOPOS trial, a vaccine trial in malignant pleural mesothelioma. Dr Lester advises
patients on all aspects of the non-surgical treatment of lung cancer, mesothelioma and urological cancers (prostate, kidney, bladder). He
is responsible for prescribing and supervising the administration of radiotherapy, radioisotope treatment, cytotoxic chemotherapy and
hormone therapy.